MTNB icon

Matinas BioPharma
MTNB

Overview Fund Activity

65 hedge funds and large institutions have $36.7M invested in Matinas BioPharma in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 11 closing their positions.

Holders
65
Holders Change
-3
Holders Change %
-4.41%
% of All Funds
1.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
16
Reduced
12
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Two Sigma Investments
1
Two Sigma Investments
New York
$991K
2
CIBC Private Wealth Group
2
CIBC Private Wealth Group
Georgia
$464K
3
BCM
3
Bridgeway Capital Management
Texas
$553K
4
Two Sigma Advisers
4
Two Sigma Advisers
New York
$305K
5
California Public Employees Retirement System
5
California Public Employees Retirement System
California
$273K

Top Sellers

1
Victory Capital Management
1
Victory Capital Management
Texas
$943K
2
BBA
2
Baker Bros. Advisors
New York
$1.62M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
Renaissance Technologies
4
Renaissance Technologies
New York
$206K
5
Morgan Stanley
5
Morgan Stanley
New York
$6K
Name Market Value Shares Shares
Change 		Shares
Change %
TRCT
76
Tower Research Capital (TRC)
New York
$0 2 – –
IA
77
IFP Advisors
Florida
– – – –
CFGS
78
Concourse Financial Group Securities
Alabama
– – – –
1 2 3
4